Dr. Borrello is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 N. Broadway
Baltimore, MD 21231Phone+1 410-955-8964Fax+1 443-287-4653- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1995 - 1998
University of ChicagoResidency, Internal Medicine, 1992 - 1995
Virginia Commonwealth University School of MedicineClass of 1992
Certifications & Licensure
FL State Medical License 2022 - 2025
MD State Medical License 1995 - 2024
IL State Medical License 1992 - 1995
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2001 Apr 01
- Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma Start of enrollment: 2005 Jun 01
- Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma Start of enrollment: 2004 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Tumor-Specific CD8T Cells from the Bone Marrow Resist Exhaustion and Exhibit Increased Persistence in Tumor-Bearing Hosts as Compared to Tumor Infiltrating Lymphocytes.Elizabeth M Zawidzka, Luca Biavati, Amy Thomas, Claudio Zanettini, Luigi Marchionni, Robert Leone, Ivan Borrello> ;Biorxiv. 2023 Aug 29
- Embracing Myeloma Chimeric Antigen Receptor-T: From Scientific Design to Clinical Impact.Hitomi Hosoya, Paula Rodriguez-Otero, Surbhi Sidana, Ivan M Borrello> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 Jun 1
- 1 citationsAllogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years.Jonathan A Webster, Madison Reed, Hua-Ling Tsai, Alexander Ambinder, Tania Jain, Amy E Dezern, Mark J Levis, Margaret M Showel, Gabrielle T Prince, Christopher S Houri...> ;Transplantation and Cellular Therapy. 2023 Mar 1
- Join now to see all
Press Mentions
Tampa General Hospital’s New Bone Marrow Transplant and Cell Therapies Unit Saved a Palm Beach County Patient’s LifeApril 1st, 2023- 5 Oncologists on the MoveJanuary 9th, 2023
- World-Renowned Myeloma Expert, Dr. Ivan Borrello, Joins TGH Cancer Institute to Lead Its Bone Marrow Transplant (BMT)and Cell Therapies ProgramDecember 9th, 2022
- Join now to see all
Grant Support
- The Role Of Myeloid Suppressor Cells In Tumor-Specific ToleranceNational Cancer Institute2007–2011
- Marrow Infiltrating Lymphocyte Immunotherapy In MyelomaNational Cancer Institute2008–2009
- Tumor Vaccines In Autologous Bone Marrow TransplantationNational Cancer Institute2001–2005
Other Languages
- Spanish, Italian, Portuguese
Hospital Affiliations
Johns Hopkins Howard County Medical CenterColumbia, Maryland
Tampa General HospitalTampa, Florida
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ivan-borrello
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
